Kristin Brown
Peter MacCallum Cancer Centre, VIC, Australia
- This delegate is presenting an abstract at this event.
Following the award of her PhD from the University of Otago in New Zealand, Dr. Kristin Brown undertook post-doctoral training at Harvard Medical School (Boston, USA). In 2016, Kristin relocated to Melbourne where she is now a group leader in the Cancer Metabolism Program and Cancer Therapeutics Program at the Peter MacCallum Cancer Centre with a joint appointment in the Department of Biochemistry and Molecular Biology at the University of Melbourne. Kristin’s research laboratory investigates the ways in which cell metabolism contributes to cancer development, cancer progression and therapy resistance. This is achieved through the integration of metabolomics, transcriptomics and proteomics data. The knowledge gained from these studies is applied to the pre-clinical development of novel anticancer therapies.
Presentations this author is a contributor to:
Cu-Later AML:Inhibition of Heme Biosynthesis Triggers Cuproptosis in Acute Myeloid Leukaemia (131760)
10:00 AM
Alexander C Lewis
Session 6: Cancer dependencies and novel therapeutic technologies
Investigating post-transcriptional responses to altered glucose availability in cancer (#124)
5:40 PM
Nicola E Caine
Welcome Reception & Poster Session 1
Understanding how cancer cells adapt to changes in microenvironmental nutrient availability (#117)
5:40 PM
Alexandra A Birrell
Welcome Reception & Poster Session 1
NRF2 co-opts the SWI/SNF complex to drive liver cell plasticity (#231)
5:35 PM
Athena Jessica S Ong
Poster Session 2
CANCER 2026